Skip to main navigation Skip to search Skip to main content

Fludeoxyglucose positron emission tomography in the diagnosis of giant cell arteritis

  • Alla Turlakow
  • , Henry W.D. Yeung
  • , John Pui
  • , Homer Macapinlac
  • , Evan Liebovitz
  • , Valerie Rusch
  • , Andre Goy
  • , Steven M. Larson
  • Memorial Sloan-Kettering Cancer Center
  • New York Presbyterian Hospital

Research output: Contribution to journal › Article › peer-review

107 Scopus citations

Abstract

We describe a case in which fludeoxyglucose F 18 positron emission tomography (PET) led directly to the diagnosis of giant cell arteritis in an elderly woman with a fever of unknown origin. The patient presented with a 3-month history of fatigue, fever, headache, visual disturbance, jaw claudication, and anemia. A computed tomographic scan showed an anterior mediastinal mass that was suspected of being malignant. A fludeoxyglucose F 18 PET scan performed for preoperative evaluation identified striking uptake of fludeoxyglucose F 18 in the walls of the entire aorta, left main coronary artery, and subclavian, carotid, and common iliac arteries bilaterally, suggestive of an arteritis, a diagnosis subsequently confirmed by the findings of an arterial biopsy. Her erythrocyte sedimentation rate was 129 mm/h. There was normalizaton of the PET scan 2 weeks following treatment with prednisolone. This case suggests that fludeoxyglucose F 18 PET contributes to the noninvasive diagnosis of giant cell arteritis, as well as to the evaluation of the extent of disease, response to therapy, and disease recurrence.

Original languageEnglish
Pages (from-to)1003-1007
Number of pages5
JournalArchives of Internal Medicine
Volume161
Issue number7
DOIs
StatePublished - 9 Apr 2001

Fingerprint

Dive into the research topics of 'Fludeoxyglucose positron emission tomography in the diagnosis of giant cell arteritis'. Together they form a unique fingerprint.

Cite this